Randomized Trial Comparing Hand-sewn End-to-End or Kono-S and Stapled Side-to-Side Anastomosis after Ileocolic Resection for Crohns Disease to Reduce Recurrence
Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2023-12-18
165
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating surgical techniques used after ileocolic resection in patients with Crohns disease. The study compares handsewn anastomosis methods, including end-to-end and Kono-S techniques, with stapled side-to-side anastomosis. The goal is to see which method results in less recurrence of disease visible by endoscopy at 6 months, better bowel function, and potentially lower health care use.
Participants will be randomly assigned to receive either the stapled side-to-side anastomosis, performed using a linear stapler as per local practice and guidelines, or a handsewn anastomosis, either the Kono-S or end-to-end technique. The handsewn methods involve sewing the bowel ends together by hand, with the Kono-S being an anti-mesenteric functional end-to-end approach. These surgeries take place during ileocolic resection for Crohns disease.
During the study, participants will undergo follow-up assessments including endoscopy at 6 months to check for disease recurrence, clinical and histologic evaluations, and questionnaires about bowel function and quality of life. Additional monitoring includes tracking complications within 30 days after surgery, healthcare usage, medication needs, and reoperation rates for up to 5 years. The total study follow-up includes assessments at 3, 6, and 12 months postoperatively.
CONDITIONS
Brief Title
Comparing Hand-sewn (END-TO-END or Kono-S) to Stapled Anastomosis in Ileocolic Resection for Crohn's Disease
Research Team
A
Anouck EG Haanappel, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead Sponsor
ZonMw: The Netherlands Organisation for Health Research and Development
Collaborating Sponsor
Who Can Participate
Age: 16Years +
All Genders
Eligibility Criteria
You may qualify if you...
Males and females aged >16 years
Ileocolic disease or disease of the neoterminal ileum with an indication for resection
Concurrent therapies with corticosteroids, 5-ASA drugs, thiopurines, MTX, antibiotics, and anti-TNF therapy are permitted
All patients should have undergone a colonoscopy and a recent update of imaging (e.g. Ultrasound, MR enterography or CT enterography if MR is contraindicated)
Ability to comply with protocol
Competent and able to provide written informed consent
Patient must have been discussed in the local multidisciplinary team (MDT)
You will not qualify if you...
Inability to give informed consent
Patients less than 16 years of age
Clinically significant medical conditions within 6 months before surgery such as myocardial infarction, active angina, congestive heart failure, or other conditions that compromise safety
History of cancer within 5 years which might influence prognosis
Emergent operation
Pregnant or breastfeeding
Inability to follow up at 3, 6, and 12 months for postoperative assessment, imaging, and endoscopy
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Surgery and Immediate Post-operative Care
Duration - Up to 30 days after surgery
Participants undergo ileocolic resection surgery with either handsewn or stapled anastomosis followed by immediate post-operative care.
1 surgical visit and approximately 1 post-operative visit within 30 days
Post-operative Follow-up
Duration - Up to 1 year after surgery
Participants are monitored for endoscopic and clinical recurrence of Crohn's disease and other health outcomes.
Visits at 3, 6, and 12 months post-surgery for assessments including endoscopy and imaging
Long-term Monitoring
Duration - Up to 5 years after surgery
Participants are followed for long-term outcomes including reoperation rates and health care utilization.
Annual follow-up visits for up to 5 years
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Long-term Safety Follow-up of ALLO-ASC-CD in Adults With Crohns Disease Previously Treated in Phase 1 Trial
A Master Protocol Evaluating Multiple Treatments for Adults With Moderately to Severely Active Ulcerative Colitis or Crohns Disease
Real-World Study of Guselkumab Treatment in Adults with Moderate to Severe Ulcerative Colitis or Crohns Disease in Saudi Arabia
Phase 4 Open-Label Study to Measure TREMFYA Levels in Breast Milk of Lactating Women Receiving Treatment
A Study Comparing a Smartphone Application and Human Therapist for Psychological Wellbeing in Adults with Crohns Disease
Evaluation of Rectal Administration of a Specific Probiotic to Improve Gut Health in Adults with Mild-to-Moderate Ulcerative Colitis
Pilot Study Using a Retrograde Tethered Capsule Endomicroscope to Image the Lower Gastrointestinal Tract in Adults
International Real-World Study Evaluating Persistence with Guselkumab in Moderate to Severe Crohns Disease and Ulcerative Colitis
Comparing Guselkumab and Risankizumab Treatments for Moderate to Severe Crohns Disease
A Phase 3b Randomized Study Evaluating Efficacy and Safety
Evaluating the Safety and Effectiveness of Icotrokinra Compared to Placebo in Adults With Moderate to Severe Crohns Disease
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Optimising surgical anastomosis in ileocolic resection for Crohn's disease with respect to recurrence and functionality: two international parallel randomized controlled trials comparing handsewn (END-to-end or Kono-S) to stapled anastomosis (HAND2END and the End2End STUDIES).
Anouck E G Haanappel, Vittoria Bellato, Christianne J Buskens...